Introduction
Psychological problems including mood disorders have long been of interest in the clinical management of type 1 diabetes mellitus, since poor metabolic control may affect cognitive function and mood. Depression on its own may also severely hamper self-control in diabetic patients thereby inducing a vicious circle of poor control and risk of future complications [1, 2] . A number of reports have assessed the prevalence of depression among diabetic patients and a meta-analysis covering a large number of studies involving adults with different types of diabetes and using a range of methods concluded that the risk of depression was doubled among diabetic patients [3] . Even higher differences were indicated in a recent review covering studies on type 1 diabetic adults, in which the prevalence of depression in controlled studies was estimated to be around four times higher in the diabetic than the non-diabetic groups. However, the authors recommend that the results should be viewed with caution as different methods of diagnosis were used and the number of participants was small [4] .
The SEARCH for Diabetes in Youth Study, focusing on young people (10-21 years) with diabetes using self-reported questionnaires for depression, found that 14% of the diabetic individuals experienced mild, and 8.6% moderate or severely depressed, mood [5] . A longitudinal study by Kovacs et al. [6] estimated that, after 10 years of follow up, psychiatric disorders had occurred among almost half of the patients at a mean age of 20 years and major depression had occurred in around a quarter. Few studies have related the prevalence of depression in type 1 diabetes to that in controls. Popkin et al. [7] found that the prevalence of depression among individuals with longstanding type 1 diabetes awaiting pancreas transplantation was 10.7% compared with 2.9% in their firstdegree relatives (and potential donors) [7] . Furthermore, in adults with new onset type 1 diabetes, the prevalence of depression was twice that of controls [8] . However, Kokkonen found no difference in the prevalence of depression comparing young adults with type 1 diabetes to those who were medically well [9] . Since treatment of depression may improve metabolic control in diabetes [10, 11] it has been suggested that screening for depression should be recommended in young patients with diabetes. Apart from the manifestation of diabetes in itself, other diabetes-specific risk factors for depression have included the occurrence of late complications, persistent poor glycaemic control and hypoglycaemia problems [12] .
In the general population, female sex, lack of social support, low socioeconomic status, the occurrence of critical life events, ethnicity and some cultural factors have been associated with depression, not least among adolescents and young adults [13] [14] [15] [16] .
Most previous studies on depression in young people with diabetes are small and clinical based and the data are mainly from the USA. In this paper we use population-based Swedish databases that provide a unique opportunity to:
1. explore in a population-based study the prevalence of antidepressant (AD) use in young adults with childhood onset type 1 diabetes; 2. describe and compare risk determinants for AD prescription among diabetic patients and a group of matched controls.
Methods
The Swedish Childhood Diabetes Registry (SCDR) is a longitudinal research project recording incident cases of type 1 diabetes since 1 July 1977, which to date has collected more than 16,000 prospective cases following informed consent from the parents [17] . The SCDR enrols children who are diagnosed with type 1 diabetes with onset before 15 years of age and reside in Sweden at the time of diagnosis. The level of coverage is 96-99% and is ascertained by internal revisions and matching to official population registers [18] . For the present analyses, the SCDR database was linked to the Swedish National Drug Register (NDR) and the Hospital Discharge Register (HDR) at the National Board of Health, and the Labor Market Research database (LMR) at Statistics Sweden using a unique personal identification number (PIN) [19] [20] [21] . Data from these registers have been found to be valid and have been used extensively in research [22] . We defined in advance which variables we wanted to include in the analysis. We then did a one-time withdrawal of data from the various databases, and we performed all analyses on that retrieved data. After linking, coded data sets without personal identification were returned to the researchers for further analyses. For each type 1 diabetes case, Statistics Sweden selected four population controls, matched by age at type 1 diabetes diagnosis and residential community, who were alive at the time of diagnosis of the case [23] . The study was approved by the Regional Ethics Review Board at Umeå University and by the ethics committees at the National Board of Health and Statistics Sweden, respectively.
Data in the NDR and HDR are at the individual level, whereas the LMR contains data both at individual and household levels. The NDR is maintained by the National Board of Health and Welfare and contains, since 1 July 2005, individual data on pharmaceutical drugs dispensed through Swedish pharmacies prescribed by physicians, dentists and other licensed healthcare personnel. Each pharmaceutical product prescribed and dispensed for personal use is recorded with its name, the anatomical therapeutic chemical (ATC) code [24] , date of prescription, date of collection by the patient, amount and price, together with the unique PIN for the individual for whom the drug was prescribed. The information is sent automatically from the local pharmacies to the NDR database. Missing or incomplete data are found in <0.5% of cases [25] .
The HDR, also maintained by the National Board of Health and Welfare, contains individual level data, using the unique PIN for the person being admitted to hospital, on date of admission for in-patient hospital care, date of discharge and main diagnosis at discharge.
The LMR is a database maintained by Statistics Sweden containing individual as well as household level data, again using the unique PIN of the person for whom information is collected. The database accumulates data on demographics, education, employment and income, including that from salaries and various benefits, e.g. sick leave compensation, unemployment benefits, pensions and social support. The information in the database is collected prospectively from several official sources and extensively matched to ensure validity [26] . Several of the socioeconomic markers used in the present analysis are based on multiple variables in the LMR database, e.g. one which states that a person has received unemployment benefits yes/no and a second one which states what amounts have been paid in unemployment benefits to that person. We cross-checked all such variables to ensure validity. The Swedish educational system has 9 years of compulsory schooling followed by 3 years of voluntary high school. After high school, graduates can proceed to college or university.
From the NDR, all individuals indexed in the SCDR as having type 1 diabetes, and control subjects who were alive and 18 years of age or older on 1 January 2006, were assessed as to whether they had been prescribed and collected ADs (ATC codes N06AA-N06AX) at any time during the period 1 January 2006 to 31 December 2007. From the LMR, data were collected on education (highest attained), income, family size (number of children), employment status (including receipt of unemployment benefits, social benefits or disability pension), and parental education, income, and their receipt of unemployment benefits, social benefits, and disability pension during 2005 (i.e. the year before AD prescription). From the HDR, any discharge from hospital during the period 1 January 2004 to 31 December 2005 was registered together with the main hospital diagnosis according to ICD-10 (www.who.int/classifications/icd/en/) [27] . Somatic diagnoses were defined as the main diagnosis made at discharge excluding psychiatric (ICD-10 codes F00-F99), obstetric (ICD-10 codes O00-O99) and perinatal (ICD-10 codes P00-P96) diagnoses. The somatic diagnoses include in-hospital care for type 1 diabetes. A diagnosis of depression at discharge included the ICD-10 codes F31-34, F38, F39 and F41.
Statistical analyses Descriptive data are presented as means and SDs or as frequencies. Logistic regression models were fitted with prescription of AD as the dependent variable in the type 1 diabetes and control cohorts separately, using PASW 18.0. Missing data were removed from the analysis. The level of missing data was low, for most variables <2.5%. However, the variables of paternal social welfare and disability pension had 12.2% missing values. Associations with covariates are measured with ORs and are presented with 95% CIs. Covariates of known or suspected relation to the risk of being prescribed AD were first investigated univariately, and if significant they were entered step-wise into a multivariate logistic regression model. The models were subsequently stratified by sex. The final model is a joint model for both type 1 diabetes and control cohorts. Here, the presence of type 1 diabetes starting in childhood was explored as a risk factor for prescription of AD, both in a univariate and a multivariate model.
Results

Basic characteristics
In the type 1 diabetes cohort there were 7,411 and in the control cohort 30,043 individuals who were ≥18 years of age and alive on 1 January 2006 (Table 1 ). There was a slight male predominance in both groups. Mean and maximum ages in the type 1 diabetes and control cohorts were similar, but the relative frequencies of several of the socioeconomic and health related factors differed between the type 1 diabetes and control groups. Fewer in the type 1 diabetes group had children or had education beyond high school. The proportion having been on sick leave or receiving disability pension and social support was higher in the type 1 diabetes cohort. Also, a higher proportion among the type 1 diabetes cohort had been discharged from hospital, either with a somatic or a depression diagnosis. Among the parental background characteristics, only parental age differed, where both paternal and maternal ages were significantly higher in the type 1 diabetes group.
Univariate risk factors for AD prescription The distribution of risk factors associated with having been prescribed ADs during the 2 year study period was similar in the two cohorts (Table 2) , with female sex, having been discharged with a diagnosis of depression from hospital, having received support socially or economically, and receiving disability pension showing the strongest association to AD prescription in terms of ORs. In both cohorts, the prescription of ADs was related to sex, with women being at least twice as likely to be prescribed ADs as men, and age, with increasing age being linked to a higher risk. Not having children was associated with a higher risk of AD prescription, but in the sex-stratified analysis in the control group, this risk was statistically significant in men only (OR 1.5, 95% CI 1.29, 1.75; women, OR 1.1, 95% CI 0.99, 1.25).
Impaired socioeconomic status, as mirrored by unemployment or requirement for social support, was associated with higher AD prescription risk. Health related factors, such as any periods of sick leave in the year prior to being prescribed AD, receiving disability pension or having been discharged from hospital with a somatic or depression diagnosis were all associated with increased risk of AD prescription. For both sick leave and receiving disability pension there was significant sex interaction, as male sex was associated with higher risk.
As expected, the number of hospitalisations was higher in the type 1 diabetes group than in the control group, but for both groups, hospitalisation for a somatic diagnosis was a risk factor for AD. In addition, the number of hospitalisations for depression was higher in the type 1 diabetes group (0.6% vs 0.3%, Fisher's exact test p00.002, in the type 1 diabetes and control group, respectively). However, it was a significant risk factor for AD prescription in both groups. There was no significant interaction between sex and either hospitalisation for a somatic diagnosis or hospitalisation for depression. Neither age at diagnosis of type 1 diabetes nor duration of diabetes was associated with the risk of being prescribed ADs (data not shown).
In the control cohort, maternal education beyond 12 years of schooling was associated with a lower risk for AD prescription in the progeny (OR 0.8, 95% CI 0.76, 0.94), with a similar, but non-significant tendency in the type 1 diabetes group (OR 0.8, 95% CI 0.71, 1.02). Paternal education beyond 12 years of schooling was not associated with the risk of AD prescription (data not shown). Parental factors lowering the socioeconomic status and associated with parental poor health were significantly associated with higher risk, among the children, of being prescribed ADs in both the type 1 diabetes and control groups ( Table 2) . Parental age was not associated with risk for AD prescription (data not shown).
Multivariate, within group analyses The multivariate models for the type 1 diabetes and control groups respectively (Table 3) show similar patterns of risk factors for AD prescription, with hospitalisation for depression and being on disability pension or on sick leave having the highest ORs. In both groups, having an education beyond high school and the mother being on sick leave become non-significant in the multivariate model.
Secondary, pooled multivariate analysis
In a secondary analysis of our case-control design, we pooled type 1 diabetes cases and controls to further analyse whether type 1 diabetes is an independent risk factor for AD prescription (Table 4) . In univariate analysis, type 1 diabetes was associated with a 44% higher risk (OR 1.44, 95% CI 1.32, 1.58). When adjusting for the potential confounders, including sex, age and various socioeconomic risk factors, this risk increase was no longer statistically significant (OR 1.11, 95% CI 0.99, 1.24). Hospitalisation for depression, receiving disability pension, having been on sick leave, and receiving social support remained factors with the strongest association with being prescribed AD. Interaction terms for diabetes and the socioeconomic variables were investigated and found to be not significant (data not shown).
Discussion
In the present large sample of young adults, the presence of childhood onset type 1 diabetes was associated with a 44% increased risk of receiving AD compared with matched nondiabetic individuals. This estimate of increased risk is in agreement with, or slightly lower than, other reports indicating that diabetes is a risk factor for depression [3] [4] [5] . The higher prevalence reported in some reports is probably due to differences in age range, as the present study included a younger age group. In separate analyses, the patterns of risk factors associated with prescription of AD were similar in the type 1 diabetes and control cohorts. In a secondary analysis, combining the two cohorts and adjusting for well-known, mainly socioeconomic and general health related, risk factors for depression such as hospitalisations, sick leave and receiving disability pension, having type 1 diabetes was only associated with a small increase in risk that did not reach statistical significance. There was no statistically significant interaction between type 1 diabetes and the socioeconomic variables, indicating that the impact of socioeconomic status on AD usage was not dependent on the presence of diabetes (i.e. there was no effect modification). Psychiatric illnesses (ICD-10 codes F00-F99) were the most common reasons for both sick leave and disability pension in young adults as well as in the older age groups (i.e. the parents) and explain in total some 25% of disability pensions (personal communication, A. Kolk, National Social Insurance system, Unit for Statistical Analysis). Among young adults, mood disorders including depression contribute to 16% of disability pensions [28] . We do not have information on somatic or psychiatric illness in the parents, which we believe would have contributed significantly to the model, further decreasing the effect of diabetes [29] . However, we did include indicators of parental socioeconomic status, including parental sick leave and disability pension, which were found to be significantly associated with AD prescription in their children. Low socioeconomic status in parents is a wellknown risk factor for poor health, including depression, in the offspring [30, 31] . Although the present study cannot clearly answer the question of whether low socioeconomic status in the present setting leads to depression or vice versa, prospective studies indicate that lower socioeconomic status increases the risk of subsequent depression [32] . These results indicate that diabetes per se (i.e. aberrations in glucose metabolism) is not clearly associated with an increased risk of depression, as previously suggested [1] . The increase in risk in young people with diabetes compared with age-matched controls would thus mainly depend on their higher prevalence of socioeconomic risk factors, which is in contrast to previous studies. The exact mechanism through which type 1 diabetes contributes to this higher prevalence of socioeconomic risk factors still remains to be elucidated, although two reviews point towards the negative effect of type 1 diabetes in educational achievements and adult employment [33, 34] . Chronic poor health in childhood may, per se, be a factor in academic underachievement and difficulties in becoming established on the labour market [31] . We have previously shown, in data from the SCDR, that children with type 1 diabetes have lower school marks than reference children [35] , but also that children of mothers who had childhood onset type 1 diabetes have lower school marks [36] .
The present register study used prescribed and dispatched AD medicine as a proxy for depression and clearly the individual cause for being prescribed such medicine may vary, although depression is the most common indication for AD use [37] . In diabetes, as well as in other chronic medical conditions, psychiatric co-morbidity, such as clinical depression, may be under-diagnosed as well as under-treated, despite the fact that both depressive symptoms and glycaemic control respond well to both pharmacological and psychotherapeutic treatment [38] . In a recent population-based study from Finland [39] AD prescription was studied over a 10 year period (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) in diabetes cases, including all types and age groups, using a nationwide prescription register similar to the Swedish one. That study found that AD use was more common among diabetic compared with non- diabetic individuals, and the risk increases were similar to those in our study (RR 1.5-1.6 in both men and women, 15-44 years of age). Importantly, there was a rapid prevalence increase among the youngest age groups. Our prevalence data on AD prescription in the control group are similar to those recently published on AD use among Swedish 20-34 year olds [40] and our findings that a hospital diagnosis of depression was strongly associated with AD prescription supports the use of AD as a proxy for depression. Gendelman and co-workers [41] reported that 14.5% of type 1 diabetic men and 20.1% of type 1 diabetic women scored high enough on the Beck Depression Inventory (BDI) II to be classified as being at least mildly depressed, without being under treatment, compared with 3.6% of nondiabetic men and 7.8% of non-diabetic women. This may indicate that our study only captured the more severe cases.
The strength of our study is that it is exceptionally large and population based and that it was possible to link data from official administrative registers measuring socioeconomic factors at an individual level. In addition, the data on AD use have high validity, coming from automatic, individual level, actual prescription and collection records gathered from nationwide surveillance at local pharmacies, reducing recall bias and the missing information that comes from a reluctance to surrender sensitive facts in questionnaires and interviews. However, we cannot oversee the possibility that there are random validity problems when using official register data. Thus, we interpret the findings in the present study as showing that it is the sum of the socioeconomic variables that affect AD prescription, not putting emphasis on any specific variable. Furthermore, depression of such magnitude that it requires AD medication indicates more severe cases, and the associations between ADs and socioeconomic factors found in the present study may not be relevant in milder forms of depression. Still, the results give firm information on the socioeconomic risk factors for AD and clearly, already at very young age, such risk factors are more prevalent among type 1 diabetic patients.
In conclusion, the present study does not support the theory that childhood onset type 1 diabetes per se is a risk factor for mood disorders that lead to increased use of ADs, but that socioeconomic risk factors for such use are more prevalent in young people with diabetes than in controls. The message is then that diabetes clinics must be aware of this, and try to prevent long term sick leave and disability pension and, from an early age, work closely with social services, since social deprivation in diabetes may lead to co-morbidity such as depression, possibly instigating the vicious circle of depressed mood, poor metabolic control and diabetes-related complications.
